Isarna Therapeutics GmbH
Industry
- Biotechnology
- Large Molecule
- Antisense, Oligonucleotides
- Pharmaceuticals
Other Names/Subsidiaries
- Antisense Pharma GmbH
Latest on Isarna Therapeutics GmbH
IN VITRO DIAGNOSTICS Mergers & Acquisitions DNA Diagnostics Center MTS Health Investors sold DNA Diagnostics Center (DDC) to London-based GHO Capital for $110mm (€104mm). (Oct.) Through the acquis
IN VITRO DIAGNOSTICS Eventus Diagnostics Inc. Eventus completes $2.7mm second round Eventus Diagnostics Inc. (cancer) raised $2.7mm through what appears to be its Series B round led by a new p
Munich-based Isarna Therapeutics GMBH has raised €13 million ($17.8 million) in new funding and signed agreements with Roche Innovation Center Copenhagen AS and Sanofi following its restru
Cell therapy firm Apceth has appointed Dr Stefanos Theoharis to the newly created position of chief business officer. Prior to joining Munich, Germany-based Apceth – a developer of stem cell-based the